Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the Randomized Trial to Evaluate the Relative PROTECTion against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia among Antiplatelet and Antithrombotic Agents - Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30)

Authors :: Gibson, C. Michael
Kirtane, Ajay J.
Morrow, David A.
Palabrica, Theresa M.
Murphy, Sabina A.
Stone, Peter H.
Scirica, Benjamin M.
Jennings, Lisa K.
Herrmann, Howard C.
Cohen, David J.
McCabe, Carolyn H.
Braunwald, Eugene
Source :: American Heart Journal. Oct, 2006, Vol. 152 Issue 4, p756, 6 p.
Publication Year :: 2006

Subjects :: Cardiac patients -- Research
Cardiac patients -- Physiological aspects
Heart attack -- Research
Heart attack -- Physiological aspects
Biological markers -- Usage
Coronary heart disease -- Research
Coronary heart disease -- Physiological aspects
Blood platelets -- Aggregation
Blood platelets -- Usage
Blood platelets -- Research
Health

Tools